Invesaro

Stocks REPL Earnings

Earnings

Replimune Group, Inc. (REPL) earnings

Quarterly results of Replimune Group, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when REPL files with the SEC.

Next earnings date

Replimune Group, Inc. is expected to report around February 2, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2027

In Q2 FY2027 (ended September 30, 2026) Replimune Group, Inc. reported revenue of - and a net loss of $57.1M.

Diluted earnings per share were -$0.54.

Filed with the SEC on November 6, 2026.

Net income by quarter
Q3 25: -$66.3M -$66.3M Q3 25Q4 25: -$74.1M -$74.1M Q4 25Q1 26: -$86.7M -$86.7M Q1 26Q2 26: -$83.1M -$83.1M Q2 26Q3 26: -$70.9M -$70.9M Q3 26Q4 26: -$73.2M -$73.2M Q4 26Q1 27: -$69.8M -$69.8M Q1 27Q2 27: -$57.1M -$57.1M Q2 27

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2027September 30, 2026---$57.1M-$0.54
Q1 FY2027June 30, 2026---$69.8M-$0.72
Q4 FY2026March 31, 2026---$73.2M-
Q3 FY2026December 31, 2025---$70.9M-$0.77
Q2 FY2026September 30, 2025---$83.1M-$0.90
Q1 FY2026June 30, 2025---$86.7M-$0.95
Q4 FY2025March 31, 2025---$74.1M-
Q3 FY2025December 31, 2024---$66.3M-$0.79

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Replimune Group, Inc.'s next earnings date?

Replimune Group, Inc. is expected to report around February 2, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when REPL reports

Follow REPL and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when REPL files with the SEC.

Source: quarterly figures Replimune Group, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Replimune Group, Inc.